85 related articles for article (PubMed ID: 26682383)
1. Breast Cancer Tissue Marked Selectively by Magnetic Nanoparticles in an Experimental Animal Model.
Silva JG; Lopez J; Sánchez V; Lozano LM; González CA
J Nanosci Nanotechnol; 2015 Dec; 15(12):9591-6. PubMed ID: 26682383
[TBL] [Abstract][Full Text] [Related]
2. c-erbB-2 as a possible target for the use of magnetic nanoparticles in breast cancer cells.
Silva-Escobedo JG; Sanchez-Monroy V; Rojas-Lopez M; Lopez-Cruz J; González CA
IEEE Trans Nanobioscience; 2014 Sep; 13(3):300-7. PubMed ID: 25014961
[TBL] [Abstract][Full Text] [Related]
3. Expression of c-erbB-2 in breast cancer cell lines as experimental receptor of magnetic nanoparticles.
Silva JG; Sánchez V; Polo SM; González CA
Annu Int Conf IEEE Eng Med Biol Soc; 2013; 2013():4498-501. PubMed ID: 24110733
[TBL] [Abstract][Full Text] [Related]
4. A Comparative Study of Receptor-Targeted Magnetosome and HSA-Coated Iron Oxide Nanoparticles as MRI Contrast-Enhancing Agent in Animal Cancer Model.
Erdal E; Demirbilek M; Yeh Y; Akbal Ö; Ruff L; Bozkurt D; Cabuk A; Senel Y; Gumuskaya B; Algın O; Colak S; Esener S; Denkbas EB
Appl Biochem Biotechnol; 2018 May; 185(1):91-113. PubMed ID: 29082480
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional superparamagnetic nanoparticles conjugated with fluorescein-labeled designed ankyrin repeat protein as an efficient HER2-targeted probe in breast cancer.
Li DL; Tan JE; Tian Y; Huang S; Sun PH; Wang M; Han YJ; Li HS; Wu HB; Zhang XM; Xu YK; Wang QS
Biomaterials; 2017 Dec; 147():86-98. PubMed ID: 28938164
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Value of ER, PR, FR and HER-2-Targeted Molecular Probes for Magnetic Resonance Imaging in Patients with Breast Cancer.
Jin YH; Hua QF; Zheng JJ; Ma XH; Chen TX; Zhang S; Chen B; Dai Q; Zhang XH
Cell Physiol Biochem; 2018; 49(1):271-281. PubMed ID: 30138940
[TBL] [Abstract][Full Text] [Related]
7. Functionalized magnetic dextran-spermine nanocarriers for targeted delivery of doxorubicin to breast cancer cells.
Tarvirdipour S; Vasheghani-Farahani E; Soleimani M; Bardania H
Int J Pharm; 2016 Mar; 501(1-2):331-41. PubMed ID: 26875475
[TBL] [Abstract][Full Text] [Related]
8. Detectability of Her2 positive tumors using monoclonal antibody conjugated iron oxide nanoparticles in MRI.
Oghabian MA; Jeddi-Tehrani M; Zolfaghari A; Shamsipour F; Khoei S; Amanpour S
J Nanosci Nanotechnol; 2011 Jun; 11(6):5340-4. PubMed ID: 21770186
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical assay (IHC) to study C-erbB-2 status of breast cancer using monoclonal antibody CIBCgp185.
Meenakshi A; Kumar RS; Ganesh V; Sivakumar N
Hum Antibodies; 2003; 12(4):123-7. PubMed ID: 15156100
[TBL] [Abstract][Full Text] [Related]
10. Phagocytosis of breast cancer cells mediated by anti-MUC-1 monoclonal antibody, DF3, and its bispecific antibody.
Akewanlop C; Watanabe M; Singh B; Walker M; Kufe DW; Hayes DF
Cancer Res; 2001 May; 61(10):4061-5. PubMed ID: 11358826
[TBL] [Abstract][Full Text] [Related]
11. Smart Bacterial Magnetic Nanoparticles for Tumor-Targeting Magnetic Resonance Imaging of HER2-Positive Breast Cancers.
Zhang Y; Ni Q; Xu C; Wan B; Geng Y; Zheng G; Yang Z; Tao J; Zhao Y; Wen J; Zhang J; Wang S; Tang Y; Li Y; Zhang Q; Liu L; Teng Z; Lu G
ACS Appl Mater Interfaces; 2019 Jan; 11(4):3654-3665. PubMed ID: 30495920
[TBL] [Abstract][Full Text] [Related]
12. Decorated Superparamagnetic Iron Oxide Nanoparticles with Monoclonal Antibody and Diethylene-Triamine-Pentaacetic Acid Labeled with Thechnetium-99m and Galium-68 for Breast Cancer Imaging.
de Souza Albernaz M; Toma SH; Clanton J; Araki K; Santos-Oliveira R
Pharm Res; 2018 Jan; 35(1):24. PubMed ID: 29305666
[TBL] [Abstract][Full Text] [Related]
13. Dual-target recognition sandwich assay based on core-shell magnetic mesoporous silica nanoparticles for sensitive detection of breast cancer cells.
Wang W; Liu S; Li C; Wang Y; Yan C
Talanta; 2018 May; 182():306-313. PubMed ID: 29501157
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody conjugated magnetic nanoparticles could target MUC-1-positive cells in vitro but not in vivo.
Shanehsazzadeh S; Gruettner C; Lahooti A; Mahmoudi M; Allen BJ; Ghavami M; Daha FJ; Oghabian MA
Contrast Media Mol Imaging; 2015; 10(3):225-36. PubMed ID: 25327822
[TBL] [Abstract][Full Text] [Related]
15. A sandwich-type electrochemical immunosensor based on in situ silver deposition for determination of serum level of HER2 in breast cancer patients.
Shamsipur M; Emami M; Farzin L; Saber R
Biosens Bioelectron; 2018 Apr; 103():54-61. PubMed ID: 29278813
[TBL] [Abstract][Full Text] [Related]
16. Radiation binary targeted therapy for HER-2 positive breast cancers: assumptions, theoretical assessment and future directions.
Mundy DW; Harb W; Jevremovic T
Phys Med Biol; 2006 Mar; 51(6):1377-91. PubMed ID: 16510950
[TBL] [Abstract][Full Text] [Related]
17. In vivo examination of (188)Re(I)-tricarbonyl-labeled trastuzumab to target HER2-overexpressing breast cancer.
Chen KT; Lee TW; Lo JM
Nucl Med Biol; 2009 May; 36(4):355-61. PubMed ID: 19423002
[TBL] [Abstract][Full Text] [Related]
18. Optimization of the Working Conditions for Magnetic Nanoparticle-Enhanced Microwave Diagnostics of Breast Cancer.
Bellizzi G; Bellizzi GG; Bucci OM; Crocco L; Helbig M; Ley S; Sachs J
IEEE Trans Biomed Eng; 2018 Jul; 65(7):1607-1616. PubMed ID: 28922111
[TBL] [Abstract][Full Text] [Related]
19. HER2 targeting as a two-sided strategy for breast cancer diagnosis and treatment: Outlook and recent implications in nanomedical approaches.
Colombo M; Corsi F; Foschi D; Mazzantini E; Mazzucchelli S; Morasso C; Occhipinti E; Polito L; Prosperi D; Ronchi S; Verderio P
Pharmacol Res; 2010 Aug; 62(2):150-65. PubMed ID: 20117211
[TBL] [Abstract][Full Text] [Related]
20. Targeting of human breast cancer by a bispecific antibody directed against two tumour-associated antigens: ErbB-2 and carcinoembryonic antigen.
Dorvillius M; Garambois V; Pourquier D; Gutowski M; Rouanet P; Mani JC; Pugnière M; Hynes NE; Pèlegrin A
Tumour Biol; 2002; 23(6):337-47. PubMed ID: 12677091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
